J. Lemire

发表

Immunomodulatory actions of 1,25-Dihydroxyvitamin D3

J. Lemire, 1995, The Journal of Steroid Biochemistry and Molecular Biology.

Dietary phosphorus reduction by pretreatment of human breast milk with sevelamer

P. Grimm, E. Ferrara, J. Lemire, 2004, Pediatric Nephrology.

Immunosuppressive actions of 1,25-dihydroxyvitamin D3: preferential inhibition of Th1 functions.

H. Spiegelberg, L. Beck, J. Lemire, 1995, The Journal of nutrition.

1,25-Dihydroxyvitamin D3 Attenuates of Expression of Experimental Murine Lupus of MRL/1 Mice

J. Lemire, A. Ince, M. Takashima, 1992 .

1,25‐Dihydroxyvitamin D3 inhibits the passive transfer of cellular immunity by a myelin basic protein‐specific T cell clone

J. Adams, J. Lemire, 1992, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Decreased low-density lipoprotein receptor function and mRNA levels in lymphocytes from uremic patients.

R. Portman, R. Weinberg, D. Loose-Mitchell, 1992, Kidney international.

1 alpha,25-dihydroxyvitamin D3 suppresses proliferation and immunoglobulin production by normal human peripheral blood mononuclear cells.

J. Adams, S. Jordan, J. Lemire, 1984, The Journal of clinical investigation.

1,25-Dihydroxyvitamin D3– a hormone with immunomodulatory properties

J. Lemire, 2000, Zeitschrift für Rheumatologie.

Immunomodulatory role of 1,25‐dihydroxyvitamin D3

J. Lemire, 1992, Journal of cellular biochemistry.

1,25-dihydroxyvitamin D3 prevents the in vivo induction of murine experimental autoimmune encephalomyelitis.

J. Lemire, D. C. Archer, J. Lemire, 1991, The Journal of clinical investigation.

1,25-Dihydroxyvitamin D3 suppresses human T helper/inducer lymphocyte activity in vitro.

J. Adams, S. Jordan, A. Bakke, 1985, Journal of immunology.

Vitamin D as a Cytokine and Hematopoetic Factor

J. Adams, M. Hewison, J. Lemire, 2001, Reviews in Endocrine and Metabolic Disorders.

1,25-Dihydroxyvitamin D3 attenuates the expression of experimental murine lupus of MRL/l mice.

J. Lemire, A. Ince, M. Takashima, 1992, Autoimmunity.

CHAPTER 98 – Vitamin D3: Autoimmunity and Immunosuppression

J. Lemire, 2005 .

1,25-Dihydroxy-24-OXO-16ene-vitamin D3, a renal metabolite of the vitamin D analog 1,25-dihydroxy-16ene-vitamin D3, exerts immunosuppressive activity equal to its parent without causing hypercalcemia in vivo.

G. Reddy, J. Lemire, D. C. Archer, 1994, Endocrinology.

Pulmonary hemorrhage in children with glomerulonephritis

S. Mendoza, W. Griswold, J. Lemire, 1995, Pediatric Nephrology.

1,25-Dihydroxyvitamin D3 enhances the generation of nonspecific suppressor cells while inhibiting the induction of cytotoxic cells in a human MLR.

R. Kerman, J. Lemire, M. Meehan, 1992, Cellular immunology.

1,25-dihydroxyvitamin D3 prevents the in vivo induction of murine experimental autoimmune encephalomyelitis.

J M Lemire, D C Archer, J. Lemire, 1991, The Journal of clinical investigation.

Passive transfer of experimental allergic encephalomyelitis by myelin basic protein-specific L3T4+ T cell clones possessing several functions.

W. Weigle, J. Lemire, 1986, Journal of immunology.

Prolongation of the survival of murine cardiac allografts by the vitamin D3 analogue 1,25-dihydroxy-delta 16-cholecalciferol.

J. Lemire, M. Uskokovic, D. C. Archer, 1992, Transplantation.

Interstitial Nephritis in Children with Crohn's Disease

P. Grimm, N. Benador, G. Billman, 2000, Clinical pediatrics.

Nonsteroidal anti-inflammatory drug use in adolescence.

S. Mendoza, J. Lemire, V. Reznik, 1998, The Journal of adolescent health : official publication of the Society for Adolescent Medicine.

Everolimus in pediatric de nova renal transplant patients1

J. Kovarik, P. Niaudet, J. Mahan, 2003, Transplantation.

Treatment of an infant withCandida cystitis

R. Portman, E. Buescher, J. Corriere, 1991, Pediatric Nephrology.

Single‐dose pharmacokinetics and tolerability of everolimus in stable pediatric renal transplant patients

J. Kovarik, J. Mahan, R. Ettenger, 2002, Pediatric transplantation.

1 alpha , 25-dihydroxyvitamin D 3 suppresses proliferation and immunoglobulin production by normal human peripheral blood mononuclear cells

J. Lemire, R. Sakai, 2018 .

Fungal peritonitis in children treated with peritoneal dialysis and gastrostomy feeding

R. Portman, B. Murugasu, J. Lemire, 1991, Pediatric Nephrology.

Extracorporeal membrane oxygenation in the neonate with congenital renal disease and pulmonary hypoplasia.

R. E. Caesar, S. Mendoza, W. Griswold, 1995, Journal of pediatric surgery.

A rational dosing algorithm for basiliximab (Simulect) in pediatric renal transplantation based on pharmacokinetic-dynamic evaluations1

J. Kovarik, P. Niaudet, M. Hall, 2002, Transplantation.

A multicenter, open-label, pharmacokinetic/pharmacodynamic safety, and tolerability study of basiliximab (Simulect) in pediatric de novo renal transplant recipients

P. Niaudet, M. Hall, P. Cochat, 2002, Transplantation.

Pulmonary vasculitis with hemorrhage in anaphylactoid purpura

L. Eichenfield, G. Billman, W. Griswold, 1994, Pediatric pulmonology.

Five years' experience with cyclosporine in children.

R. Portman, C. V. van Buren, B. Kahan, 1988, Transplantation proceedings.

Mycobacterial peritonitis in pediatric peritoneal dialysis patients

P. Grimm, J. Leake, N. Benador, 2003, Pediatric Nephrology.

Cost Analysis of Dialysis Modalities for Pediatric Acute Renal Failure

S. Mendoza, B. Peterson, J. Lemire, 1993, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

The syndrome of autoimmune interstitial nephritis and membranous nephropathy

H. Krous, H. Spiegelberg, N. Wilson, 1997, Pediatric nephrology (Berlin, West).

Hais cuaj txub kaum txub—To Speak of All Things: A Hmong Cross-cultural Case Study

N. Benador, V. Reznik, J. Lemire, 2004, Journal of Immigrant Health.

Neoral pharmacokinetics in Latino and Caucasian pediatric renal transplant recipients

E. Capparelli, P. Grimm, N. Benador, 2001, Pediatric Nephrology.

Evaluation of tolerability and ability to increase immunosuppression in renal transplant patients converted from mycophenolate mofetil to enteric-coated mycophenolate sodium.

J. Wolff, J. Lemire, J. Bilodeau, 2009, Transplantation proceedings.

The various renal manifestations of the nephropathic form of cystinosis.

B. Kaplan, J. Lemire, 1984, American journal of nephrology.

Transient hemiparesis associated with monoclonal CD3 antibody (OKT3) therapy.

D. Trauner, J. Lemire, V. Reznik, 1993, Pediatric neurology.

The role of vitamin D3 in immunosuppression: lessons from autoimmunity and transplantation.

D. Feldman, J. Lemire, 1997 .

Rapid Publication 1 a,25-Dihydroxyvitamin D3 Suppresses Proliferation and Immunoglobulin Production by Normal Human Peripheral Blood Mononuclear Cells

Y. Okamura-Oho, J. Adams, S. Jordan, 2022 .

MULTICENTER STUDY OF THE SAFETY AND TOLERABILITY OF BASILIXIMAB (SIMULECT®) IN DE NOVO PEDIATRIC RENAL TRANSPLANTATION.: Abstract# 568

M. Hall, P. Cochat, C. Loirat, 2000 .

BASILIXIMAB [SIMULECT®] DRAMATICALLY REDUCES ACUTE REJECTION AFTER PEDIATRIC KIDNEY TRANSPLANTATION.: Abstract# 576

P. Grimm, Rodney J. Taylor, J. Sherbotie, 2000 .

Immunosuppressive actions of 1,25-dihydroxyvitamin D3: preferential inhibition of Th1 functions.

H. Spiegelberg, L. Beck, J. Lemire, 1995, The Journal of nutrition.

Myelin basic protein-specific T cell clones and experimental allergic encephalomyelitis.

W. Weigle, J. Lemire, 1986, Pathology and immunopathology research.